These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31817415)

  • 1. Metabolic Alterations in Cardiomyocytes of Patients with Duchenne and Becker Muscular Dystrophies.
    Esposito G; Carsana A
    J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31817415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy.
    Meyers TA; Townsend D
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31443395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency.
    Lopez JR; Kolster J; Zhang R; Adams J
    J Mol Cell Cardiol; 2017 Jul; 108():149-157. PubMed ID: 28623080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients.
    Capitanio D; Moriggi M; Torretta E; Barbacini P; De Palma S; Viganò A; Lochmüller H; Muntoni F; Ferlini A; Mora M; Gelfi C
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):547-563. PubMed ID: 31991054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-induced cardiac injury in dystrophic mice.
    Stelter Z; Strakova J; Yellamilli A; Fischer K; Sharpe K; Townsend D
    Am J Physiol Heart Circ Physiol; 2016 Apr; 310(7):H938-48. PubMed ID: 26851247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
    Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I
    Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results.
    Palladino A; Papa AA; Morra S; Russo V; Ergoli M; Rago A; Orsini C; Nigro G; Politano L
    Acta Myol; 2019 Mar; 38(1):1-7. PubMed ID: 31309174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystrophin-Deficient Cardiomyopathy.
    Kamdar F; Garry DJ
    J Am Coll Cardiol; 2016 May; 67(21):2533-46. PubMed ID: 27230049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart transplantation in patients with dystrophinopathic cardiomyopathy: Review of the literature and personal series.
    Papa AA; D'Ambrosio P; Petillo R; Palladino A; Politano L
    Intractable Rare Dis Res; 2017 May; 6(2):95-101. PubMed ID: 28580208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
    Guo Y; Petrof BJ; Hussain SN
    Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart.
    Burelle Y; Khairallah M; Ascah A; Allen BG; Deschepper CF; Petrof BJ; Des Rosiers C
    J Mol Cell Cardiol; 2010 Feb; 48(2):310-21. PubMed ID: 19769982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A
    Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways.
    Jung C; Martins AS; Niggli E; Shirokova N
    Cardiovasc Res; 2008 Mar; 77(4):766-73. PubMed ID: 18056762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition.
    Tanihata J; Nagata T; Ito N; Saito T; Nakamura A; Minamisawa S; Aoki Y; Ruegg UT; Takeda S
    Biochem Biophys Res Commun; 2018 Oct; 505(1):51-59. PubMed ID: 30236982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the mysteries of Duchenne and Becker muscular dystrophy.
    Hyser CL
    Mol Chem Neuropathol; 1989 Feb; 10(1):15-20. PubMed ID: 2660836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eliminating Nox2 reactive oxygen species production protects dystrophic skeletal muscle from pathological calcium influx assessed in vivo by manganese-enhanced magnetic resonance imaging.
    Loehr JA; Stinnett GR; Hernández-Rivera M; Roten WT; Wilson LJ; Pautler RG; Rodney GG
    J Physiol; 2016 Nov; 594(21):6395-6405. PubMed ID: 27555555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
    Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
    Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study.
    Hoogerwaard EM; Bakker E; Ippel PF; Oosterwijk JC; Majoor-Krakauer DF; Leschot NJ; Van Essen AJ; Brunner HG; van der Wouw PA; Wilde AA; de Visser M
    Lancet; 1999 Jun; 353(9170):2116-9. PubMed ID: 10382696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.